WHO ICTRP trial
Oral L-tyrosin for reversing gray hair; a clinical trial
ACTRN12613001277730 · Australian New Zealand Clinical Trials Registry (ANZCTR) · Not Recruiting
Key facts
| Trial ID | ACTRN12613001277730 |
|---|---|
| Public title | Oral L-tyrosin for reversing gray hair; a clinical trial |
| Scientific title | The effect of supplementary oral L-tyrosin plus other essential elements (Dr Daniel capsule for gray hair) on reversing gray hair |
| Primary sponsor | Daniel F Fouladi |
| Registry | Australian New Zealand Clinical Trials Registry (ANZCTR) |
| Recruitment status | Not Recruiting |
| Study type | Interventional |
| Phase | Phase 2 |
| Countries | Iran, Islamic Republic Of |
| Conditions | Gray hair; Gray hair;Alternative and Complementary Medicine - Other alternative and complementary medicine;Skin - Normal skin development and function |
| Interventions | Three groups of normal men with gray hair (total=15) will receive daily oral L-tyrosin 500 mg or 3000 mg daily plus other essential elements including 50 mg (in cases on 500 mg L-tyrosin) or 300 mg (in cases on 3000 mg L-tyrosin)… |
| Registration date | Nov 19, 2013 |
| Target size | 15 |
| Secondary IDs | None. |
| Registry page | anzctr.org.au |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: